LCM
BVS icon

Laurion Capital Management’s Bioventus BVS Stock Holding History

Laurion Capital Management’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-118,291
Closed -$615K – 578
2024
Q1 		$615K Hold
118,291
– – 0.01% 421
2023
Q4 		$623K Buy
+118,291
New +$468K 0.01% 375

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
JIC
Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Laurion Capital Management's BVS Position: Q2 2024 in Review

Laurion Capital Management sold out of Bioventus (BVS) in Q2 2024, closing a stake of 118,291 shares — an estimated $615K sold.

Laurion Capital Management first reported a position in BVS in Q4 2023 and held it in 2 quarters. The position peaked at $623K in Q4 2023. 103 funds tracked by Wall St. Rank hold BVS as of Q2 2024.

  • Laurion Capital Management reported no remaining Bioventus position as of Q2 2024 after selling out during the quarter.
  • Laurion Capital Management sold 118,291 Bioventus shares in Q2 2024, an estimated $615K.
  • Laurion Capital Management first reported a position in Bioventus in Q4 2023 and held it in 2 quarters.
  • Laurion Capital Management's Bioventus position peaked at $623K in Q4 2023.
  • 103 funds tracked by Wall St. Rank held Bioventus as of Q2 2024.

Based on Laurion Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.